SCHEMBL4371870

SCHEMBL4371870

[CH2]CCOC(=O)c1ccccc1C=C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.50
ALDH1A1 P00352 10/20 0.47
TSHR P16473 9/20 0.46
TDP1 Q9NUW8 5/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
HSD17B10 Q99714 5/20 0.44
MAPK1 P28482 3/20 0.44
TP53 P04637 2/20 0.44
LMNA P02545 1/20 0.42
NPC1 O15118 3/20 0.40
HPGD P15428 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GLA P06280 1/20 0.40
HIF1A Q16665 1/20 0.40
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1896572 0.87 CYP3A4 (0.50) CYP3A4ALDH1A1TSHRTDP1L3MBTL1
SCHEMBL4905609 0.85 ALDH1A1 (0.69) CYP3A4ALDH1A1TSHRTDP1L3MBTL1
SCHEMBL1897234 0.85 CYP3A4 (0.49) CYP3A4ALDH1A1TSHRTDP1L3MBTL1
SCHEMBL29030397 0.83 CYP3A4 (0.53) CYP3A4ALDH1A1TSHRTDP1L3MBTL1
SCHEMBL1397837 0.83 TSHR (0.71) CYP3A4ALDH1A1TSHRTDP1L3MBTL1
SCHEMBL4894269 0.81 TSHR (0.71) CYP3A4ALDH1A1TSHRTDP1L3MBTL1
SCHEMBL4906053 0.81 TSHR (0.49) CYP3A4ALDH1A1TSHRTDP1L3MBTL1
SCHEMBL1900819 0.81 TSHR (0.57) CYP3A4ALDH1A1TSHRTDP1L3MBTL1
SCHEMBL4905671 0.81 SCN1A (0.47) CYP3A4ALDH1A1TSHRTDP1L3MBTL1
SCHEMBL5064752 0.81 TSHR (0.53) CYP3A4ALDH1A1TSHRTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383470-B1 HAIR TREATMENT COMPOSITIONS UNILEVER PLC (GB) 2009-06-17 EP disclosed
EP-1383860-B1 FABRIC CARE COMPOSITIONS UNILEVER PLC (GB) 2005-10-12 EP disclosed
US-6767883-B2 Fabric care compositions UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. 2004-07-27 US disclosed
US-6696051-B2 CONTAINING CORE PARTICLES HAVING A D3,2 AVERAGE PARTICLE SIZE OF 10-700 NM, AND COATED WITH COVALENTLY BONDED SILICONE POLYMER UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2004-02-24 US disclosed
EP-1383468-A2 HAIR TREATMENT COMPOSITIONS UNILEVER PLC (GB) 2004-01-28 EP disclosed
EP-1383860-A1 FABRIC CARE COMPOSITIONS Unilever Plc (GB) 2004-01-28 EP disclosed
EP-1383470-A2 HAIR TREATMENT COMPOSITIONS UNILEVER PLC (GB) 2004-01-28 EP disclosed
US-20030095943-A1 Hair treatment compositions UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-05-22 US disclosed
US-20020192367-A1 Fabric care compositions UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2002-12-19 US disclosed
WO-2002087522-A2 HAIR TREATMENT COMPOSITIONS UNILEVER PLC (GB) 2002-11-07 WO disclosed
US-6071987-A FORMS AN ELASTOMER HAVING EXCELLENT MECHANICAL PROPERTIES UPON THE EVAPORATION OF THE VOLATILE COMPONENTS INCLUDING WATER BY HEATING TOSHIBA SILICONE CO., LTD. (JP) 2000-06-06 US disclosed
US-5916687-A Film-formable emulsion type silicone composition for air bag and air bag TOSHIBA SILICONE CO., LTD. (JP) 1999-06-29 US disclosed
EP-0822219-A2 Film-formable emulsion type silicone composition for air bag and air bag TOSHIBA SILICONE CO., LTD. (JP) 1998-02-04 EP disclosed
EP-0822232-A2 Silicone emulsion composition and process for producing silicone powder therefrom TOSHIBA SILICONE CO., LTD. (JP) 1998-02-04 EP disclosed
EP-0433727-B1 Silica-core silicone-shell particles, emulsion containing the same dispersed therein, and process for producing the emulsion TOSHIBA SILICONE (JP) 1995-08-02 EP disclosed
EP-0433906-B1 Thermoplastic resin and process for producing the same TOSHIBA SILICONE (JP) 1995-07-26 EP disclosed
US-5218014-A Graft polymer formed by graft polymerization of vinyl monomer onto colloidal silica core silicone shell particles TOSHIBA SILICONE CO., LTD. (JP) 1993-06-08 US disclosed
US-5188899-A SILICA-CORE SILICONE-SHELL PARTICLES, EMULSION CONTAINING THE SAME DISPERSED THEREIN, AND PROCESS FOR PRODUCING THE EMULSION TOSHIBA SILICONE CO., LTD. (JP) 1993-02-23 US disclosed
EP-0433906-A2 Thermoplastic resin and process for producing the same TOSHIBA SILICONE CO., LTD. (JP) 1991-06-26 EP disclosed
EP-0433727-A1 Silica-core silicone-shell particles, emulsion containing the same dispersed therein, and process for producing the emulsion TOSHIBA SILICONE CO., LTD. (JP) 1991-06-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030095943-A1 Hair treatment compositions SPTLC3, HACD3, C18orf63 CYP3A4 2556/4885ALDH1A1 379/4885TSHR 1682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.